Ocugen (NasdaqCM:OCGN) Update / briefing Transcript
Ocugen (NasdaqCM:OCGN) Update / briefing January 15, 2026 08:30 AM ET Company ParticipantsSwayampakula Ramakanth - Managing DirectorLejla Vajzovic - Clinical Trial InvestigatorJay Chablani - Clinical Trial InvestigatorHuma Qamar - CMOArun Upadhyay - Chief Scientific OfficerElemer Piros - Managing DirectorArshad Khanani - Clinical Trial InvestigatorShankar Musunuri - Chairman, CEO, and Co-FounderConference Call ParticipantsRobert LeBoyer - Senior Biotechnology AnalystMichael Okunewitch - Senior Biotechnology ...